← Eichor
Study identifier: NCT06516848 Synced from ClinicalTrials.gov · July 30, 2026
● Recruiting

High-intensity Inspiratory Muscle Training in Patients With Asthma

Condition: Asthma  ·  Sponsor: Istanbul Medipol University Hospital

PhaseNA
Planned participants34
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The aim of this study is to examine the effects of high-intensity and low-intensity inspiratory muscle training added to the standard pulmonary rehabilitation exercise program including aerobic and peripheral muscle strengthening training on respiratory muscle function, exercise capacity, dyspnea and health-related quality of life in asthmatic patients. The aim of the study was to examine whether there are intra-group changes and inter-group differences in the groups where low and high intensity inspiratory muscle training was applied. The cases meeting the inclusion criteria will be randomized and divided into two groups, the groups will be named as High Intensity Inspiratory Muscle Training Group (H-IMT) and Low Intensity Inspiratory Muscle Training Group (L-IMT).

This description comes directly from the study's public registry record.

Talk to the study team

Cahidenur Koçak  ·  +90 216 777 8 777  ·  cahidekocak@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Esra Pehli̇vanIstanbul, Üsküdar, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06516848